Biopharmaceutical company focusing on liver diseases research.
1999
France
201 - 500 employees
Biotechnology
$25M - 100M in revenue
Not profitable
CO2e per visit (g)
Industry benchmark
| Subsector | Country | Transaction date ⓘ | |||||
|---|---|---|---|---|---|---|---|
| 2022 | 2023 | 2024 | 2025 | 2026 | Total | ||
| ******* | ******* | - | - | - | ******* | ******* | ******* |
| ******* | ******* | - | - | ******* | - | - | ******* |
Powered by AlliedOffsets and illuminem
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▲ 33.2%
0.0
▼ 33.3%
0.1
▼ 11.9%
0.2
2031Available
Available
Not available
Available
5 out of 20 incl. management
Not available
Not available
Available
Not available
Not available
Not available
Not available
First certified : September 2025
Score by impact area
Community
Environment
Workers
Governance
Customers
Supply chain management impact
Industry benchmark